Early-Life Allergy Risk, Precision Diagnostics, and the Future of Prevention (ft. Dr. Anna Asarnoj)

A 7% sensitization rate by 3 months of age highlights how early allergic disease can begin, making early recognition critical for long-term patient outcomes. In this episode, internationally recognized allergy researcher and pediatric allergist Dr. Anna Asarnoj shares insights from the landmark BAMSE birth cohort and her decades of research on how allergies develop, evolve, and sometimes resolve over time. Together, we explore the atopic march, early-life sensitization, component-resolved diagnostics, pet allergen risk stratification, oral immunotherapy, and emerging strategies to prevent food allergy before it becomes clinically established. Gain practical, evidence-based insights to improve diagnostic precision, risk assessment, and long-term allergy Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/early-life-sensitization-food-allergy-risk.html?cid=0ct_3pc_05032024_9SGOV4